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Oral Bioavailability of Chromium
from a Specific Site
by Charlotte M. Witmer,* Raymond Harris,*t
and Saul 1. Shupackt
Analysis of soil from a specific site in New Jersey indicated a low level of sodium and
chromium present as a calcium compound. Chromium was then administered orally to young,
mature male rats at a level of240,g/kg for 14 days as chromium-contaminated soil, as CaCrO4, and
as an equimolar mixture ofthe soil and calcium salts for 14 days. The rats were sacrificed 24 hr
after the last dosing, and tissues were taken immediately for chromium analysis. Blood, muscle,
and liver contained the highest levels ofchromium in these animals, although kidney contained
the highest concentration per gram of tissue. The total amount of chromium in the tissues was
less than 2% ofthe administered chromium. In a study ofthe excretion ofchromium, the animals
were dosed orally for 8 days (with CaCrO4 or contaminated soil, each at the level of240pmole Cr/
kg), and the chromium in feces and urine was determined on days 1, 2, 7, and 8. After cessation of
dosing for 27 days, the same rats were dosed for 2 days at the same level, and chromium in urine
and feces was determined for the 2 days. The animals administered the chromium in soil had
higher levels of chromium in both urine and feces on all days compared to the group fed the
CaCrO4. The total recovery of chromium in any of the 2-day periods was less than 50% of the
chromium administered during that period.
Introduction
Chromium has recently been identified in several sites
in New Jersey in high concentrations as a result of sev-
eral decades of chromium work and subsequent dump-
ing of waste materials. Lagoons containing chromium
and the appearance of chromium on walls of several
buildings near the sites of chromium deposits have also
been identified. The proximity of these dumping sites
to schools and playgrounds has caused reasonable con-
cern about the oral bioavailability of the chromium in
the soil following possible ingestion by children. Very
little is known about the absorption of chromium from
the gut, particularly in children, so this is a legitimate
concern. It is known that trivalent chromium is a dietary
requirement in trace amounts (1), but hexavalent chro-
mium has been shown by epidemiological studies to
cause respiratory cancers (2,3). This study was thus
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originated because of concerns of the New Jersey De-
partment of Environmental Protection about the oral
absorption from soil from specific chromium-contami-
nated sites inJersey City. Analyses ofsoil samples from
the specific sites using the scanning electron microscope
indicated that the hexavalent chromate was present
largely as the calcium salt, a common salt of chromium
found in soil. Therefore, our studies used samples of
soil, calcium chromate, and a mixture ofthe two for the
bioavailability determinations. The resultant bioavail-
abilities of the three sources of chromium were then
compared to determine whether the soil matrix had an
effect on chromate uptake by the mammalian system.
The objectives of the study were thus the determina-
tion of chromium from the specific site in Jersey City
and the comparison of the bioavailability of the chro-
mium from the soil and from the calcium chromate salt.
A previous report ofpart ofthis work (4) reported on
the tissue distribution of the chromium after up to 14
days of oral administration of sodium and calcium
chromates as well as contaminated soil, along with ex-
cretion data from soil and calcium chromate following 2
days of treatment. This report includes some data on
tissue distribution as well as the data for excretion of
chromium on days 1, 2, 7, and 8 of treatment and the
excretion data 27 days after cessation oftreatment and
renewal oftreatment for 2 days.WITMER ET AL.
Methods
Chromium was determined using either the Baird in-
ductively coupled plasma (ICP) method (in which the
chromium is detected by atomic emission and the at-
omization is carried out by argon plasma), or by atomic
absorption, using a graphite furnace to heat the chro-
mium to the gaseous state. The ICP method is more
sensitive and was used for concentrations in the parts
per billion range. Neither instrument differentiates be-
tween chromium in the different oxidation states, how-
ever. Samples were prepared for analysis by a modifi-
cation of the acid procedure, as previously described
(4). Briefly, 0.1 g or more of the chromium-containing
sample (tissue or original soil) was weighed into a 20-
mL test tube and 1 mL of concentrated HNO3 was
added slowly, followed by 1 mL of 30% H202. After the
bubbling ceased, the solution was warmed in a water
bath to 600C and kept at that temperature until the
solution cleared (16 hr or more). The solutions were
then made up to 25 mL volume each with double distilled
water, and aliquots were taken for chromium analysis,
with filtering when necessary. Chromium solutions ob-
tained from Sigma Chemical Company were used to
standardize each instrument.
Analyses of several samples from the site in Jersey
City indicated that the chromium content varied be-
tween 0.2 and 3.6%. Samples were obtained with the
cooperation ofthe New Jersey Department ofEnviron-
mental Protection and they had been sized when
received by our group. Soil samples with the highest
chromium concentration (Pacific Avenue Fines [PAC])
were used for the in vivo experiments to allow for the
greatest possible oral ingestion from such samples.
Analysis for the oxidation states ofchromium using the
carbazide method (5) indicated that 30 to 35% of the
chromium was hexavalent, but samples were not homo-
geneous, and because the oxidation state of chromium
changes with storage under various conditions, this
analysis was not considered to be accurate but was con-
sidered to be an indication of the maximum hexavalent
concentration. Analysis for some elements other than
chromium was carried out with preliminary experiments
using a Hitachi Scanning Electron Microscope S-570
equipped with a PGT System 4 Microanalyzer. The high
calcium content ofthe soil along with a low sodium con-
tent suggested that the chromium was present as a
calcium salt.
The Pacific Avenue sample analysis was in agreement
with the chromium analysis but analysis for other ele-
ments was limited to 0.1% accuracy. No manganese was
found in the soils tested by this procedure.
Healthy, male Sprague-Dawley rats of 80 to 120 g
weight (Taconic Farms, Boyertown, PA) were used as
the experimental animals. The rats were acclimated to
the vivarium for several days before experiments and
were kept with a light/dark cycle of 12 hr each through
all studies. Calcium and sodium chromates were pur-
chased from Aldrich Chemical Company (Milwaukee,
WI) and were the purest available. All chromates and
soil were administered per os at the doses indicated for
each experiment, and the rats were sacrificed 24 hr
after the last treatment.
Animals treated with chromium or control solutions
were weighed and dosed daily between 9 and 10 A.M. and
sacrificed by either anesthesia and exsanguination
through the abdominal aorta. All organs for analysis
were immediately removed and weighed; total organs
were used except for the liver. A small piece (approxi-
mately 100 mg) ofthe liver was taken for analysis. The
following organs were taken for analysis after dosing,
except as otherwise noted: liver, lung, spleen, kidney,
muscle, brain, and testes. An aliquot of blood from the
abdominal aorta was also analyzed for chromium.
Experimental Design and Results
Initial pilot studies with oral administration of 0, 20,
40, and 100 ,umole/kg of hexavalent chromium (as Na2
CrO4*4H20, dissolved in distilled water) to four groups
of rats for 7 days indicated that, ofthe organs studied,
liver, blood, and kidney contained the highest amount
of chromium. With the concentration expressed as mi-
crograms per gram organ, however, the kidney con-
tained the highest concentration ofchromium (4). In the
animals dosed with 100 ,umole/kg, the total amount of
chromium in the tissues represented only 1.7% of the
amount administered in the previous 24 hr. Animals
given doses less than 100 ,umole/kg showed less than
0.1% recover ofchromium in tissues.
Doses of 120 ,umole Cr/kg were administered orally to
four groups of rats for 7 days, using four sources of
chromium: a) Na2CrO4, b) CaCrO4, c) PAC-soil, and d)-a
mixture ofsoil and calcium chromate containing 60 ,umole
Cr/kg each. Subsequent analysis ofthe tissues showed
that the kidney contained a higher concentration of
chromium (ng/g tissue) than any other tissue studied
(4). On a total organ basis, the liver contained the
greatest amount of total chromium. In these studies,
the absorption from the soluble sodium salt was gener-
ally higher in all tissues studied than from either the
calcium salt, soil, or a mixture of calcium salt and soil
(4). However, the recovery of chromium in the tissues
studied accounted for less than 2% ofthe total adminis-
tered dose. If the calculations were made on the basis
of the chromium administered in the last dose prior to
sacrifice, the percentage was approximately 4%.
In another experiment using the same three sources
of chromate (calcium salt, soil, and a mixture of the
calcium salt and soil) all orally administered as corn oil
suspensions, with a much higher dose (240 gmole Cr/kg)
and longer time ofadministration (14 days oftreatment),
the total tissue levels of chromium from any of the
groups mimicked the distribution of the previous ex-
periments with the exception that the blood levels were
higher than those of the kidney (on a chromium/gram
tissue basis) (Fig. 1). The recovery in the tissues again
represented a small percentage (<1.5%) of the total
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FIGURE 1. Tissue levels ofchromium. Rats were administered eithercalcium chromate, chromate-contaminated soil, or amixture ofthe two, orally,
asdesignated inthe figure, for 14days at alevel of240,umole Cr/kgbodyweight. They were sacrificed onday 15byetheranesthesia andbleeding
from the abdominal aorta. Tissues were analyzed for chromium using the ICP method. Chromium levels are per gram tissue.
chromium administered. The recovery was also very
low even if the percentage was based on the amount
given in the last dose before sacriflce (4). This small
percentage ofrecovery from both a hexavalent (CaCrO4)
and trivalent source (soil was calculated to contain about
70% of the chromium as the trivalent form) suggested
an unusually low absorption from oral administration,
even from the hexavalent compound, with a very rapid
excretion of the chromium (within 24 hr of absorption),
or a redistribution of absorbed chromium followed by
rapid excretion. Another possibility is that untested
tissues contained high amounts ofchromium.
To determine whether the major portion ofthe orally
administered chromium was rapidly excreted, urine and
feces were collected and analyzed for chromium follow-
ing dosing of rats with 240 ,umole Cr/kg suspended in
corn oil. The rats (three/group) were housed in metabolic
cages and dosed daily at this level with chromium as
the calcium salt and as the chromium-contaminated soil.
Control rats received corn oil. Dosing was carried out
for 8 days, once daily, between 9 and 10 A.M. Urine and
feces were collected at 6, 12, and 24 hr after dosing. In
the first part of the experiment, urine and feces were
collected on days 1 and 2 and on days 7 and 8. The
experiment was continued after day 8 by cessation of
chromium administered from 27 days and then redosing
the animals for 2 days (designated days 1B and 2B)
during which time the urine and feces were again col-
lected at the same time periods, for 2 days. In all these
experiments the metabolic cages were plastic and con-
tained nalgene partitions which separated the urine and
feces immediately. Both urine and feces were prepared
for analysis oftotal chromium as previously described,
and aliquots were analyzed using the ICP method. The
excretion results showing the total chromium found in
each time period for the several groups and the com-
parison of the total chromium excreted for each group
are shown in Figures 2 through 9.
The data in these figures indicated that chromium is
not excreted to an appreciable extent in the urine from
either of the treated groups, but significant amounts
are excreted in some feces. The chromium content in
urine from CaCrO4 rats on days 1 and 2 was < 0.5% of
the total administered dose. The urinary excretion in
the rats dosed with the soil was somewhat higher, the
average amount being 1.80% of the 2-day dose. The
chromium content of the feces of rats that were dosed
with soil on days 1 and 2 was much greater than that in
feces ofrats fed the calcium salt, the recover percentages
being 19 and 1.80%, respectively. The urinary excretion
values can be used as a measure of absorption of chro-
mium from the gastrointestinal tract, and thus the values
seem to substantiate the conclusions based on tissue
levels, that little chromium is absorbed from the oral
route. However, the low fecal values indicated that the
total administered chromium was not excreted rapidly.
The excretion patterns in urine and feces on days 7
and 8 as well as on days 1 and 2 in the second part of
the experiment also indicated that more of the chro-
mium from soil is excreted in both feces and urine than
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FI;uRE 2. Chi-omium excretion in urine on (lays 1 an(d 2. Rats weie
tieatedorallywitheithei-contiolvehicle (coi-noil),calciumchromate,
or chromium-contaminated soil at a level of 240 pmole Ci/kg daily
between 9 an(l 10 A.Ni., dui-ing these 2 (lays. Ui-ine an(l feces weie
collected at 6, 12, an(d 24 hi- after dosing and pi-epaied foi- chi-omium
analysis by oxidation as (lesciibe(l in the text. Chi-omium wsas
(letermine(l on aliquots ofthe samples using the ICP methodl. Chi o-
mium levels shown ale for each time l)eriodl as well as for the total
24-hr periodl.
the chi-omium from the CaCi-04-treated rats. For ui-ine
collected on days 7 and 8 of the study, the pei-centage of
the recovei-y of chi-omium foi- soil-tieated animals was
1.12% of the dose and that foi- CaCr04-treated animals
was 0.21%. Fecal excretion was 40.6% and 12.35% foi- the
soil and CaCI-04 gioups, respectively. Data foi- CaCrOF-
treated i-ats in the resumed studies (days 1B and 2B)
show that the uiinary excretion of chromium averaged
0.44% ofthe dose for soil-tieated i-ats and avei-aged 0.1%
for the CaCrO4-treated animals. Fecal exci-etion was much
higher for both groups: 42.92% foi- the soil group and
2.92% for the CaCrO,-treated group.
CHROMIUM EXCRETION IN URINE DAYS 7 AND 8
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tieeated orally with conti-ol vehicle oL with calcium chromate or
chromium-contaminate(d soil as (lesci-ibe(l foi Figure 2. Feces were
prepared foi- analysis by oxidlation as (lescribedl in the text, and the
chromium was (letermine(l using the ICP method. Chromium levels
are shown as (lescriibe(l foi Figure 2.
The rats had a low feces output in the 12 hi- aftei- the
oial close, and the 12- to 24-hi- pei-iod feces contained
the majoi pei-centage (about 90% ofthe fecal output) of
the chi-omium foi- the i-ats in both ofthese gioups.
In two-thii-ds of the i-ats in the second part of the
studly, thei-e were no feces in the first 6 hr. The urinai-y
patterns were moi-e level in that the chiomium output
at each time pei-iod was highei- fiom the soil-tieated
animals. These studies also show that the excretion is
not so rapid as to clear the chromium from the system
within 24 hi-, so the low tissue recovery percentages
aie not accounted for by i-apid exci-etion.
The percent exci-etion of the administered chromium
in days 7 and 8 is significantly higher than that for the
fiist 2 days of administi-ation and slightly higher- than
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collectedl 6, 12, an(l 24 hi- aftei- losing on (lays 7 an(l 8. Ui-ines wer e
piepaie(l foi- analysis by oxidlation as (lesciibe(l in the text. Chro-
mium as (leteiminedl on ali(luots using the ICP methodl. Chromium
levels ai-e as (lesciibe(l foi- Figuiie 2.
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FI(;, E 5. Chromium excretion in feces on (lays 7 andl 8. Rats weie
tieate(l orally wvith contiol vehicle oi uvith calcium chiomate or
chiomium-contaminatedl soil as (lesciibe(l foi- Figui-e 2. Feces wei e
collectedl 6, 12, an(d 24 hi- aftei- (losing on (lays 7 and 8. Feces wei-e
prepaied foi- analysis by oxi(lation as (lesciibe(l in the text. Chio-
mium was (leteimine(l on aliquots usingthe ICP method. Chiomium
levels showz n ai-e as (lesciibedl foi- Figui e 2.
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FIGURE 6. Chromium excretion in urine on (lays 1B an(d 2B. Rats
received no doses ofchr omium for 27 clays after 8 days oftreatment
and were treated again for 2 (lays after the27-dlay interival. Doses of
calcium chromate and soil wer e as in Figur e 2 for the 2 days. Ur ine
andl feces were collecte(d at 6, 12, and 24 hr afterldosing, andl samples
were pr-epared for analysis by oxidation as (lescribed in the text.
Chromium was determine(d on aliquots using the ICP metho(l. Chro-
mium lev els ar e as (lescr ibedl for Figur e 2.
on the 2 days after readministration after cessation of
chromium treatment. The increased levels in days 7 and
8 suggest excretion of some residual chromium, and it
appears that the biological half-life of chromium is at
least several days. It also suggests that this storage of
chromium negates the use ofurinary or fecal chromium
detection as a quantitative indication of recent oral ex-
posure. The biological half-life of chromium in humans
has been estimated to be 30 days (6), but there have been
no reported half-life values for rats.
The percentage of chromium accounted for in tissues
and excreta in these experiments is not above 50% of
the administered dose even for the soil-treated animals,
which have the highest recovery of the administered
material. Langard's group (7) and others have found that
FIGURE 7. Chromium excretion in feces on days 1B and 2B. Feces of
the rats treated as describe(d for Figure 6 wer e analyzed for chro-
mium using the ICP metho(l. Chr omium levels ar e as descr ibed for
Figur e 2.
the lungs, liver, and blood contain the major amounts of
absorbed chromium. Tissues that remain to be studied,
e.g., skin, bone, intestinal, and gastrointestinal tract lin-
ing, may contain high levels of chromium and have not
yet been studied by our group. Values for these tissues
are not included in the literature. We have failed to find
chromium in bile of chromium-treated rats with
cannulated bile ducts (C. M. Witmer, unpublished re-
sults), but these animals received low doses ofchromium
(100 Mtmole/kg) and the experiments must be repeated.
Some of the older literature includes negative determi-
nations for chromium in other tissues, but these deter-
minations were carried out prior to the use of sensitive
detection methods and therefore these results may have
to be reinterpreted.
An important question to be answered that was raised
previously by our group is the location ofthe chromium
that was not found in the tissues examined and was not
excreted in the 24 hr after dosing. The red blood cells
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are known to store chromium bound to hemoglobin, but
this amount was included in our tissue studies. The ap-
parent low absorbance ofthe hexavalent chromium was
not unexpected as the hexavalent form has been shown
to be reduced in both saliva and gastricjuice (8), and the
resultant trivalent material would be poorly absorbed
through the intestinal wall. However, trivalent com-
pounds can be absorbed slowly. The mammalian system
appears to limit absorbance of the orally administered
material to a low amount; the reduction in the blood
would also prevent distribution to many tissues. It seems
that absorbance following the oral route of exposure
needs to be explored further to ascertain the limits of
absorbance and the biological half-life under different
conditions, such as intermittent exposure and with
chromium from several salts which differ in their solu-
bilities. Such studies ofmechanism ofchromium uptake
and transport are necessary for the carrying out of as-
sessment ofrisk oforal exposure to chromium in soil or
from any other source. The question of other compo-
nents of soil that may change the oxidation state ofthe
chromium as well as the binding ofthe chromium to the
soil compound the problem and indicate that we cannot
easily solve the problem of oral absorption without in-
vestigating each specific site.
Thisworkwasin supportofacontractfromthe NewJerseyDepart-
ment ofEnvironmental Protection.
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